Last 44.90 INR
Change Today 0.00 / 0.00%
Volume 0.0
PRNX On Other Exchanges
Symbol
Exchange
Mumbai
As of 5:00 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

parnax lab ltd (PRNX) Snapshot

Open
45.15
Previous Close
44.90
Day High
45.15
Day Low
44.05
52 Week High
06/9/14 - 61.00
52 Week Low
01/19/15 - 25.10
Market Cap
381.9M
Average Volume 10 Days
42.4K
EPS TTM
-3.29
Shares Outstanding
8.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PARNAX LAB LTD (PRNX)

Related News

No related news articles were found.

parnax lab ltd (PRNX) Related Businessweek News

No Related Businessweek News Found

parnax lab ltd (PRNX) Details

Parnax Lab Limited manufactures and sells pharmaceutical formulations in India. It offers liquid orals, ointments, and external powders. The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. Parnax Lab Limited was incorporated in 1982 and is based in Mumbai, India.

Founded in 1982

parnax lab ltd (PRNX) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

parnax lab ltd (PRNX) Key Developments

Parnax Lab Limited Announces Unaudited Consolidated and Standalone Earnings Results for the Third Quarter and First Nine Months Ended December 31, 2014

Parnax Lab Limited announced unaudited consolidated and standalone earnings results for the third quarter and first nine months ended December 31, 2014. For the quarter, on standalone basis, the company announced net sales or income from operations, net of excise duty of INR 47.876 million compared to INR 44.719 million a year ago. Loss from operations before other income, finance costs and exceptional items were INR 0.724 million compared to INR 0.232 million a year ago. Loss from ordinary activities before tax was INR 3.228 million compared to INR 3.117 million a year ago. Net loss was INR 3.828 million or INR 0.45 per basic and diluted share for before and after extraordinary items compared to INR 3.117 million or INR 0.37 per basic and diluted share for before and after extraordinary items a year ago. For the first nine months, on standalone basis, the company announced net sales or income from operations, net of excise duty of INR 119.777 million compared to INR 133.871 million a year ago. Loss from operations before other income, finance costs and exceptional items were INR 5.655 million compared to INR 0.168 million a year ago. Loss from ordinary activities before tax was INR 16.080 million compared to INR 9.353 million a year ago. Net loss was INR 16.080 million or INR 1.89 per basic and diluted share for before and after extraordinary items compared to INR 9.353 million or INR 1.10 per basic and diluted share for before and after extraordinary items a year ago. For the quarter, on consolidated basis, the company announced net sales or income from operations, net of excise duty of INR 286.574 million compared to INR 183.560 million a year ago. Profit from operations before other income, finance costs and exceptional items were INR 28.016 million compared to INR 16.130 million a year ago. Profit from ordinary activities before tax was INR 16.670 million compared to INR 7.425 million a year ago. Net profit was INR 16.670 million or INR 1.96 per basic and diluted share for before and after extraordinary items compared to INR 7.425 million or INR 0.87 per basic and diluted share for before and after extraordinary items a year ago. For the first nine months, on consolidated basis, the company announced net sales or income from operations, net of excise duty of INR 767.648 million compared to INR 469.066 million a year ago. Loss from operations before other income, finance costs and exceptional items were INR 75.908 million compared to INR 60.336 million a year ago. Loss from ordinary activities before tax was INR 43.443 million compared to INR 34.816 million a year ago. Net profit was INR 43.443 million or INR 5.09 per basic and diluted share for before and after extraordinary items compared to INR 34.816 million or INR 4.08 per basic and diluted share for before and after extraordinary items a year ago.

Parnax Lab Limited, Board Meeting, Feb 14, 2015

Parnax Lab Limited, Board Meeting, Feb 14, 2015. Agenda: To consider and approve unaudited consolidated and standalone earnings results for the third quarter and first nine months ended December 31, 2014.

Parnax Lab Limited Reports Unaudited Standalone and Consolidated Earnings Results for the Second Quarter and Six Months Ended Sep. 30, 2014

Parnax Lab Limited reported unaudited standalone and consolidated earnings results for the second quarter and six months ended Sep. 30, 2014. For the quarter, on standalone basis, the company reported net sales/income from operations (net of excise duty) of INR 43.343 million compared to INR 51.674 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 3.383 million compared to loss from operations before other income, finance costs and exceptional items of INR 0.299 million a year ago. Profit from ordinary activities before tax was INR 0.251 million against loss from ordinary activities before tax of INR 3.558 million a year ago. Net profit for the period was INR 0.251 million or INR 0.03 per basic and diluted share before and after extraordinary items (not annualized) compared to net loss for the period of INR 3.558 million or INR 0.42 per basic and diluted share before and after extraordinary items (not annualized) a year ago. For the six months, on standalone basis, the company reported net sales/income from operations (net of excise duty) of INR 71.901 million compared to INR 89.153 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 4.931 million compared to profit from operations before other income, finance costs and exceptional items of INR 0.065 million a year ago. Loss from ordinary activities before tax was INR 12.251 million against INR 6.235 million a year ago. Net loss for the period was INR 12.251 million or INR 1.44 per basic and diluted share before and after extraordinary items (not annualized) compared to INR 6.235 million or INR 0.73 per basic and diluted share before and after extraordinary items (not annualized) a year ago. For the quarter, on consolidated basis, the company reported net sales/income from operations (net of excise duty) of INR 269.152 million compared to INR 165.411 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 28.073 million compared to INR 24.035 million a year ago. Profit from ordinary activities before tax was INR 17.79 million against INR 15.064 million a year ago. Net profit for the period was INR 17.79 million or INR 2.09 per basic and diluted share before and after extraordinary items (not annualized) compared to INR 15.064 million or INR 1.77 per basic and diluted share before and after extraordinary items (not annualized) a year ago. For the six months, on consolidated basis, the company reported net sales/income from operations (net of excise duty) of INR 481.075 million compared to INR 285.468 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 47.892 million compared to INR 44.199 million a year ago. Profit from ordinary activities before tax was INR 26.774 million against INR 27.444 million a year ago. Net profit for the period was INR 26.774 million or INR 3.14 per basic and diluted share before and after extraordinary items (not annualized) compared to INR 27.444 million or INR 3.22 per basic and diluted share before and after extraordinary items (not annualized) a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRNX:IN 44.90 INR 0.00

PRNX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PRNX.
View Industry Companies
 

Industry Analysis

PRNX

Industry Average

Valuation PRNX Industry Range
Price/Earnings 11.6x
Price/Sales 0.4x
Price/Book 1.7x
Price/Cash Flow 6.6x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PARNAX LAB LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.